About us

Our name Enara Bio™ is derived from an Arabic word meaning illumination, enlightenment and bringing light into the darkness.

We are the leaders in exploring the hidden depths of cancer and T-cell biology to discover and characterize Dark Antigens™, a novel class of shared immunotherapy targets that arise from altered cellular processes in cancer cells. We believe that Dark Antigens have the core attributes that will enable cancer immunotherapies to improve treatment outcomes for broad patient populations.

Enara Bio is backed by prominent life science investors, including RA Capital, Pfizer Ventures, M Ventures, Samsara BioCapital and SV Health Investors. We collaborate with world-leading companies and academic institutions, such as Boehringer Ingelheim and the Francis Crick Institute, to help drive our differentiated science-led approach.

Enara Bio Our Story Poster

Leadership Team

Kevin Pojasek
President and Chief Executive Officer
David Watson
Chief Operating Officer
Sophie Papa
Chief Medical Officer and Head of Translational Science
Joseph Dukes
Chief Scientific Officer
Stacey Davis
Chief Business Officer and Chief Financial Officer

Board of Directors

Scientific Advisors & Founders

Investors

Stacey Davis

Chief Business Officer and Chief Financial Officer

Stacey joined Enara Bio in 2025 as Chief Business & Financial Officer and brings a rare blend of commercial acumen, financial expertise, strategic deal-making and entrepreneurial leadership to advance corporate strategy, business development, and operational excellence. She has over 25 years of experience in delivering growth, innovation, and strategic transformation in the biotech and pharmaceutical industries.

Stacey previously served as Chief Business Officer at Xilio Therapeutics and held senior leadership roles at Novartis Oncology, Johnson & Johnson, and Prominex. Her career spans strategic consulting, investment banking, and executive leadership in oncology, immunology, precision medicine and diagnostics. She holds a B.S.E. in biomedical engineering from Duke University.